The primary hyperoxalurias

Kidney International

Volumn 75, Issue 12, 2009, Pages 1264-1271

  Hoppe, Bernd ^a   Beck, Bodo B ^a   Milliner, Dawn S ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Nephrocalcinosis; Oxalate; Systemic oxalosis; Urolithiasis

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; ALKALI CITRATE; CITRATE POTASSIUM; CITRIC ACID; OXALIC ACID; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; SODIUM; UNCLASSIFIED DRUG;

DIET THERAPY; DISEASE COURSE; ENZYME ACTIVITY; GENE MUTATION; HUMAN; KIDNEY CALCIFICATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; OXALOSIS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; SHORT SURVEY; UROLITHIASIS;

ALCOHOL OXIDOREDUCTASES; HUMANS; HYPEROXALURIA, PRIMARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MUTATION; PYRIDOXINE; RENAL REPLACEMENT THERAPY; TRANSAMINASES;

EID: 67349122278     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.32     Document Type: Short Survey

References (57)

1. Danpure CJ. Primary hyperoxaluria: from gene defects to designer drugs. Nephrol Dial Transplant 2005; 20: 1525-1529.
2. Cregeen DP, Williams EL, Hulton S et al. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2. Hum Mutat 2003; 22: 497-506.
3. Monico CG, Persson M, Ford GC et al. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 2002; 62: 392-400.
4. Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol 2001; 12: 1986-1993.
5. 2]oxalate absorption in children with idiopathic calcium oxalate urolithiasis or primary hyperoxaluria. Kidney Int 2008; 73: 1181-1186.
6. Van Woerden CS, Groothoff JW, Wanders RJ et al. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003; 18: 273-279.
7. Hoppe B, Langman C. A United States survey on diagnosis, treatment and outcome of patients with primary hyperoxaluria. Pediatr Nephrol 2003; 18: 986-991.
8. Cochat P, Liutkus A, Fargue S et al. Primary hyperoxaluria type 1: still challenging!. Pediatr Nephrol 2006; 21: 1075-1081.
9. Hoppe B, Kemper MJ, Bökenkamp A et al. Plasma calcium-oxalate supersaturation in children with primary hyperoxaluria and end stage renal disease. Kidney Int 1999; 56: 268-274.
10. Herrmann G, Krieg T, Weber M et al. Unusual painful sclerotic like plaques on the legs of a patient with late diagnosis of primary hyperoxaluria type I. Br J Dermatol 2004; 151: 1104-1107.
11. Kopp N, Leumann E. Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 1995; 10: 2224-2227.
12. Lieske JC et al. International Registry for primary hyperoxaluria and Dent's disease. Am J Nephrol 2005; 25: 290-296.
13. Milliner DS. The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol 2005; 25: 154-160.
14. Hoppe B, Latta K, von Schnakenburg C, Kemper MJ on behalf of the Arbeitsgemeinschaft für pädiatrische Nephrologie. Primary Hyperoxaluria: the German experience. Am J Nephrol 2005; 25: 276-281.
15. Lorenzo V, Alvarez A, Torres A et al. Presentation and role of transplantation in adult patients with type 1 primary hyperoxaluria and the I244T AGXT mutation: single-center experience. Kidney Int 2006; 70: 1115-1119.
16. Coulter-Mackie, MB, Rumsby G. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis. Mol Genet Metab 2004; 83: 38-46.
17. Latta K, Brodehl J. Primary hyperoxaluria type I. Eur J Pediatr 1990; 149: 518-522.
18. Takayama T, Nagata M, Ichiyama A et al. Primary hyperoxaluria type 1 in Japan. Am J Nephrol 2005; 25: 297-302. Erratum in: Am J Nephrol. 2005; 25:416.
19. Hoppe B, Danpure CJ, Rumsby G et al. A vertical (pseudodominant) pattern of inheritance in the autosomal recessive disease primary hyperoxaluria type I. Lack of relationship between genotype, enzymic phenotype and disease severity. Am J Kidney Dis 1997; 29: 36-44.
20. de la Chapelle A, Wright FA. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci 1998; 95: 12416-12423.
21. Donaldson JC, Dise RS, Ritchie MD et al. Nephrocystin-conserved domains involved in targeting to epithelial cell-cell junctions, interaction with filamins, and establishing cell polarity. J Biol Chem 2002; 277: 29028-29035.
22. Zhang X, Roe SM, Hou Y et al. Crystal structure of alanine:glyoxylate aminotransferase and the relationship between genotype and enzymatic phenotype in primary hyperoxaluria type 1. J Mol Biol 2003; 331: 643-652.
23. van Woerden CS, Groothoff JW, Wijburg FA et al. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004; 66: 746-752.
24. Williams E, Rumsby G. Selected exonic sequencing of the AGXT gene provides a genetic diagnosis in 50% of patients with primary hyperoxaluria type 1. Clin Chem 2007; 53: 1216-1221.
25. Danpure CJ. Molecular aetiology of primary hyperoxaluria type 1. Nephron Exp Nephrol 2004; 98: e39-e44.
26. Danpure CJ, Lumb MJ, Birdsey GM et al. Alanine:glyoxylate aminotransferase peroxisome-to-mitochondrion mistargeting in human hereditary kidney stone disease. Biochim Biophys Acta 2003; 1647: 70-75.
27. Lumb MJ, Danpure CJ. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem 2000; 275: 36415-36422.
28. Rumsby G, Williams E, Coulter-Mackie M. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int 2004; 66: 959-963.
29. Pirulli D, Marangella M, Amoroso A. Primary hyperoxaluria: genotype-phenotype correlation. J Nephrol 2003; 16: 297-309.
30. Monico CG, Rossetti S, Olson JB et al. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 2005; 67: 1704-1709.
31. Kemper MJ, Conrad S, Müller-Wiefel DE. Primary hyperoxaluria type 2. Eur J Pediatr 1997; 156: 509-512.
32. Milliner DS, Wilson DM, Smith LH. Phenotypic expression of primary hyperoxaluria: comparative features of types I and II. Kidney Int 2001; 59: 31-36.
33. Monico CG, Persson M, Ford GC et al. Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 2002; 62: 392-400.
34. Monico CG, Weinstein A, Jiang Z et al. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis. Am J Kidney Dis 2008; 52: 1096-1103.
35. Hoppe B, Leumann E. Hyperoxaluria. In: Blau N, Hoffmann G, Leonard J, Clarke J (eds). Physician's Guide to the Treatment and Follow-up of Metabolic Diseases. Springer Verlag: Heidelberg, 2005 pp 279-285.
36. Leumann EP, Dietl A, Matasovic A. Urinary oxalate and glycolate excretion in healthy infants and children. Pediatr Nephrol 1990; 4: 493-497.
37. Hoppe B, Leumann E, Milliner D. Urolithiasis in childhood. In: Geary D, Schäfer F (eds). Comprehensive Pediatric Nephrology. Elsevier/WB Saunders: New York, 2008 pp 499-525.
38. Rumsby G, Sharma A, Cregeen DP et al. Primary hyperoxaluria type 2 without L-glycericaciduria: is the disease under-diagnosed? Nephrol Dial Transplant 2001; 16: 1697-1699.
39. Marangella M, Petrarulo M, Vitale C et al. Plasma and urine glycolate assays for differentiating the hyperoxaluria syndromes. J Urol 1192; 148: 986-989.
40. Marangella M, Petrarulo M, Mandolfo S et al. Plasma profiles and dialysis kinetics of oxalate in patients receiving hemodialysis. Nephron 1992; 60: 64-70.
41. Monico CG, Rossetti S, Schwanz HA et al. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. J Am Soc Nephrol 2007; 18: 1905-1914.
42. Leumann E, Hoppe B, Neuhaus T. Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol 1993; 7: 207-211.
43. Hamm LL. Renal handling of citrate. Kidney Int 1990; 38: 728-735.
44. Milliner DS, Eickholt JT, Bergstralh EJ et al. Results of long term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria. N Engl J Med 1994; 331: 1553-1558.
45. Hatch M, Freel RW, Vaziri ND. Regulatory aspects of oxalate secretion in enteric oxalate elimination. J Am Soc Nephrol 1999; 10: S324-S328.
46. Jiang Z, Asplin JR, Evan AP et al. Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 2006; 38: 474-478.
47. Hatch M, Freel RW. Intestinal transport of an obdurate anion: oxalate. Urol Res 2005; 33: 1-16.
48. Hatch M, Cornelius J, Allison M et al. Oxalobacter sp. reduces urinary oxalate excretion promoting enteric oxalate excretion. Kidney Int 2006; 69: 1-8.
49. Hoppe B, Beck B, Gatter N et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type I (PH I). Kidney Int 2006; 70: 1305-1311.
50. Illies F, Bonzel KE, Wingen AM et al. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int 2006; 70: 1642-1648.
51. Hoppe B, Graf D, Offner G et al. Oxalic acid elimination in children with chronic renal failure: comparison between hemodialysis and peritoneal dialysis. Pediatr Nephrol 1996; 10: 488-492.
52. Bunchman TE, Swartz RD. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD. Perit Dial Int 1994; 14: 81-84.
53. Jamieson NV, European PHI Transplantation Study Group. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. Am J Nephrol 2005; 25: 282-289.
54. Saborio P, Scheinman JI. Transplantation for primary hyperoxaluria in the United States. Kidney Int 1999; 56: 1094-1100.
55. Hoppe B, Kemper MJ, Bokenkamp A et al. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 1999; 56: 268-274.
56. Monico CG, Milliner DS. Combined liver-kidney and kidney alone transplantation in primary hyperoxaluria. Liver Transplantation 2001; 7: 954-963.
57. Nolkemper D, Kemper MJ, Burdelski M et al. Long term results of preemptive liver transplantation in primary hyperoxaluria type 1. Pediatr Transplant 2000; 3: 177-181.